Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank86
3Y CAGR+12.8%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+12.8%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$27.58M+22.0%
2024$22.60M-33.8%
2023$34.16M+77.6%
2022$19.23M+1357.8%
2021$1.32M+102.3%
2020$-57.28M-3094.9%
2019$-1.79M-373.1%
2018$-379000.00-